Management &
Strategic Consulting
Overview
Our extensive experience across a wide range of health economics applications in a variety of settings means that there are not many problems that are new to us. We bring this deep experience to management consulting and strategic consulting in an array of settings. We have advised on product commercialization, program evaluation, market entry, capacity expansion, market positioning, and much more.
Types Of Engagements
- Data analysis and strategic advising on market expansion for a large U.S. health system
- Strategic advising on market entry & timing
- Survey research to determine optimal value messaging for novel products & services
- Advising on evidence generation to support commercialization of medical devices, diagnostics, & pharmaceuticals
- Return-on-investment (ROI) simulation models for novel products & services
- Systematic & comprehensive summaries of literature & evidence in support of strategic advising
- Publications in peer-reviewed journals
Key Staff
- John Schneider, PhD
- Anthony LoSasso, PhD
- Robert Ohsfeldt, PhD
- Cara Scheibling, MBA
- Jacie Cooper, MS
Related Markets & Industries
- Insurance & Third-Party Payers
- Medical Services
- Hospitals & Health Systems
- Pharmaceuticals & Biotechnology
- Medical Devices & Diagnostics
- Private Equity & Venture Capital
- Consumer Products
Related Publications
- Challenges for decision-makers when assessing within-class comparative effectiveness: the case of anticoagulation therapy for atrial fibrillation. 2022
- Assessing the impact of state “opt-out” policy on access to and costs of surgeries and other procedures requiring anesthesia services. 2017
- Outcomes of Surgeries Performed in Physician Offices Compared With Ambulatory Surgery Centers and Hospital Outpatient Departments in Florida. 2017
- Cost impact of unexpected disposition after orthopedic ambulatory surgery associated with category of anesthesia provider. 2016
- Organizational boundaries of medical practice: the case of physician ownership of ancillary services. 2012
- Effects of health savings account-eligible plans on utilization and expenditures. 2011
- International comparison of comparative effectiveness research in five jurisdictions: insights for the US. 2010
- The effect of physician and health plan market concentration on prices in commercial health insurance markets. 2008
- Factors associated with Iowa rural hospitals’ decision to convert to critical access hospital status. 2008
- The economics of specialty hospitals. 2008
- Effects of specialty hospitals on the financial performance of general hospitals, 1997-2004. 2007
- Effect of critical access hospital conversion on patient safety. 2007
- Clinical practice guidelines and organizational adaptation: a framework for analyzing economic effects. 2006
- The Business of Health. 2006
- Implementation of hospital computerized physician order entry systems in a rural state: feasibility and financial impact. 2005
- What would be the effect of referral to high-volume hospitals in a largely rural state? 2004
- Changes in the Effects of Mandatory Rate Regulation On Growth in Hospital Operating Costs, 1980–1996. 2003
Related Issue Briefs
- Economic Evaluation and Market Access for Medical Devices in the U.S.: Implications of a U.S. Health Technology Assessment Agency (Issue Brief No. 53)
- Economic Cycles and Product Development in Life Sciences (Issue Brief No. 49)
- How Important is ICER Preparation and Review for U.S. Market Access? (Issue Brief No. 43)
- Using Payer Research to Assess Medical Device Market Access (Issue Brief No. 42)
- Healthcare Use Cases for Blockchain Technology (Issue Brief No. 41)
- The Value of Biopharmaceutical Innovation in the U.S. (Issue Brief No. 38)
- The Evolving Landscape of U.S. Payer Coverage Decisions: The Role of Health Economics and Outcomes Research (Issue Brief No. 37)
- Will Changes in the Affordable Care Act Result in Organizational Changes in U.S. Medical Care? Implications for Economic Evaluation of Drugs & Devices (Issue Brief No. 36)
- Medical Device Economics and the Health System Purchaser in the Era of Novel Payment Mechanisms (Issue Brief No. 35)
- Value-Based Payment for Oncology Services (Issue Brief No. 34)
- Why Medical Device Companies Need to Develop Economic Evidence in the U.S. (Issue Brief No. 33)
- Purchasing Medical Innovation: The Implications for the Medical Device Industry (Issue Brief No. 31)
- Controlling the Costs of Clinical Laboratory Testing in Medical Practice (Issue Brief No. 29)
- The New Era of Cost Control in Healthcare: What Should you look for in a Health Economics and Outcomes Research Consultant? (Issue Brief No. 27)
- Paying for Specialty Pharmaceuticals: The Case of Injectable Oncology Drugs (Issue Brief No. 26)
- Integration of Novel Diagnostics into Clinical Practice (Issue Brief No. 25)
- How Should Health Care Providers Measure and Market the Value of their Services? (Issue Brief No. 23)
- Return-on-Investment of Workplace Health Promotion Programs (Issue Brief No. 17)
- Value-Based Purchasing for Hospital Services in the U.S. (Issue Brief No. 11)
- Reshaping the Clinical Laboratory in the Era of Patient-Centered Outcomes, Accountable Care Organizations, and Pharmacogenomics (Issue Brief No. 10)
- Training the Health Economics and Outcomes Research Workforce of the Future: Opportunities for Program Development in Colleges and Universities (Issue Brief No. 4)
- The Declining Health of the Local Market: When and How Should Your Health Care Business Expand into New Markets (Issue Brief No. 3)